Edition:
United Kingdom

Nymox Pharmaceutical Corp (NYMX.OQ)

NYMX.OQ on NASDAQ Stock Exchange Capital Market

4.20USD
23 Apr 2018
Change (% chg)

$0.01 (+0.24%)
Prev Close
$4.19
Open
$4.18
Day's High
$4.33
Day's Low
$4.12
Volume
22,833
Avg. Vol
43,386
52-wk High
$5.10
52-wk Low
$3.00

Select another date:

Mon, Feb 5 2018

BRIEF-Nymox Announces U.S. NDA For Fexapotide For BPH

* SAYS ‍RECENTLY HAD A PRE-NDA MEETING WITH FDA; NDA FOR FEXAPOTIDE FOR BPH​ WILL BE SUBMITTED LATER IN 2018 Source text for Eikon: Further company coverage:

BRIEF-Nymox Reports 5-Yr Results From Prostate Cancer Study Of Fexapotide Triflutate In 146 U.S. Men

* NYMOX REPORTS 5-YEAR RESULTS FROM PROSPECTIVE RANDOMIZED CONTROLLED PROSTATE CANCER STUDY OF FEXAPOTIDE TRIFLUTATE IN 146 U.S. MEN

BRIEF-Nymox Pharmaceutical posts qtrly loss $0.09/shr - SEC filing‍​

* Nymox Pharmaceutical Corp qtrly loss per share $0.09 - SEC filing‍​ Source text: (http://bit.ly/2j7iBgX) Further company coverage:

Select another date: